http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022135578-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d42d445a771ee30222eddbe900c23c70
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B41-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
filingDate 2021-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_054e6b39ad977cafd84758244cf1bcb3
publicationDate 2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022135578-A1
titleOfInvention Preparation and Application of A 5-bromoquinazoline Derivative
abstract A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: n n n n n n n n n n the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, carrying out column chromatography separation by using dichloromethane and absolute methanol according to a volume ratio of 1:1, and obtaining a target crystal compound I; the application of the 5-bromoquinazoline derivative compound crystal (I), as a catalyst has a good catalytic effect in nitrile silicification reaction of benzaldehyde and auto-polymerization reaction of benzophenone hydrazone, the conversion rates thereof respectively reach 39% and 76%, and the crystal (I) can be used as an anti-cancer reagent which has certain anti-cancer activity of breast cancer, liver cancer and lung cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115304536-A
priorityDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45158755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165020905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226430000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165094556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229302850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227706740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165069511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471507033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471515191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165023953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471511788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID477038892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471600702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471569498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167049256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165016637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407820

Total number of triples: 48.